Prospective, non-randomized staged pivotal clinical study to assess the safety and performance of the Xeltis Hemodialysis Access graft: Xeltis aXess US Pivotal
Clinical Trial Grant
Administered By
Surgery, Vascular and Endovascular Surgery
Awarded By
Xeltis, Inc.
Start Date
December 12, 2025
End Date
January 31, 2036
Administered By
Surgery, Vascular and Endovascular Surgery
Awarded By
Xeltis, Inc.
Start Date
December 12, 2025
End Date
January 31, 2036